(Q44060087)

29 November 2017

Striatal monoaminergic terminals in Lewy body and Alzheimer's dementias (English)

1 reference

29 November 2017

0 references

1 reference

Masahiko Suzuki

1

1 reference

29 November 2017

Timothy J Desmond

series ordinal

2

1 reference

29 November 2017

Roger L Albin

series ordinal

3

1 reference

29 November 2017

Kirk A Frey

series ordinal

4

1 reference

29 November 2017

1 June 2002

1 reference

29 November 2017

1 reference

29 November 2017

51

1 reference

29 November 2017

6

1 reference

29 November 2017

767-771

1 reference

29 November 2017

1 reference

Extrapyramidal signs in patients with probable Alzheimer disease.

21 January 2018

1 reference

Pathological correlates of extrapyramidal signs in Alzheimer's disease

21 January 2018

1 reference

In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies.

21 January 2018

1 reference

Clinical and positron emission tomographic studies in the 'extrapyramidal syndrome' of dementia of the Alzheimer type.

21 January 2018

1 reference

Striatal uptake of the dopamine reuptake ligand [11C]beta-CFT is reduced in Alzheimer's disease assessed by positron emission tomography.

21 January 2018

1 reference

Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly

21 January 2018

1 reference

[3H]methoxytetrabenazine: a high specific activity ligand for estimating monoaminergic neuronal integrity

21 January 2018

1 reference

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers

21 January 2018

1 reference

Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.

21 January 2018

1 reference

Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra

21 January 2018

1 reference

Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism.

21 January 2018

1 reference

Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease.

21 January 2018

1 reference

The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.

21 January 2018

1 reference

Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation

21 January 2018

1 reference

Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease

21 January 2018

1 reference

Temporal lobe central benzodiazepine binding in unilateral mesial temporal lobe epilepsy

21 January 2018

1 reference

Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.10186

1 reference

29 November 2017

1 reference